Key APM Considerations in the COVID-19 Environment

The COVID-19 outbreak has ushered in unprecedented governmental and regulatory changes, including those impacting Alternative Payment Models (APMs), quality reporting, and clinical transformation. In recent weeks, the Centers for Medicare and Medicaid Services (CMS) has announced several extensions, waivers, and other efforts to provide regulatory relief as healthcare providers are facing extraordinary challenges given the current pandemic.

It would be easy to miss multiple strategic points embedded within these announcements. This installment of our FORWARD communication series rises above the details to summarize key impacts to the provider community currently managing patients in downside risk models. Taking these summary level impacts into consideration will empower forward-looking providers to manage their risk while building their organizational APM capability.

CONTRIBUTORS

Craig Tolbert
Principal, DHG Healthcare
Craig.Tolbert@dhg.com
© Dixon Hughes Goodman LLP. All rights reserved.
DHG is registered in the U.S. Patent and Trademark Office to Dixon Hughes Goodman LLP.
praxity